Seelos Therapeutics Inc (SEEL)

[Dimitrios George]

I think the nervousness we all share has nothing to do with the BOD or new CEO...or as far as I am concerned with the old CEO. What it has to do with is the fact that Abbott, except for the $2.5M payment to the company last fall, has not said a word about the product. That is just a fact.

Now I attribute this to just how Abbott does business. On the other message board that silence, by some, is interpreted to mean that Abbott will either never launch or that they are delaying the launch to depress the price of Apricus to a point where a takeover (by Abbott) is easier.

I don't "buy" any of that nonsense as it doesn't hold water. Abbott is a large pharma and has a contractual obligation. Abbott paid $2.5M last fall. The BOD continues to have confidence in the launch this half and company statements have said they are working with Abbott, meaning they have contact. No glitch has surfaced in pricing or product manufacturing. Were there a glitch the BOD would likely know and lower its level of confidence. Finally, the company's finances are far from being an issue in terms of having to run out for dilution or seek rescue.

So we wait.